MANILA, Philippines — There is currently no reason for the Philippines to stop the rollout of AstraZeneca’s COVID-19 vaccine despite reports that some people who received the shots in some European countries have developed blood clots, the Department of Health (DOH) and the Food and Drug Administration (FDA) said Friday.
“At present, the DOH and FDA emphasize that there is no indication for the Philippines to stop rollout of AstraZeneca vaccines. The DOH, NTF (National Task Force against COVID-19) and FDA are closely coordinating on thismatter. The public is assured they will closely monitor all deployed vaccines,” the two agencies said in a joint statement.
The DOH and the FD…
Keep on reading: DOH not stopping AstraZeneca vaccination despite blood clot concerns in EU